Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|August 28, 2025
Protein Marker-Dependent Drug Discovery Targeting Breast Cancer Stem CellsAshley V Huang, Yali Kong, Kan Wang, et al.
Frontiers in Oncology|June 2, 2012
Effects of a fluorescent Myosin light chain phosphatase inhibitor on prostate cancer cellsScott Grindrod, Simeng Suy, Shannon Fallen, et al.
Bioorganic & Medicinal Chemistry|October 13, 2006
Discovery of diphenyl amine based sodium channel blockers, effective against hNav1.2Debjani P Hudgens, Catherine Taylor, Timothy W Batts, et al.
Clinical Prostate Cancer|July 29, 2004
Thalidomide and analogues: current proposed mechanisms and therapeutic usageW Nathaniel Brennen, Carlton R Cooper, Scott Capitosti, et al.
Bioorganic & Medicinal Chemistry|March 13, 2017
Development of a novel near-infrared fluorescent theranostic combretastain A-4 analogue, YK-5-252, to target triple negative breast cancerYali Kong, Jacqueline Smith, Kongwen Li, et al.
Bioorganic & Medicinal Chemistry|February 26, 2004
Synthesis and evaluation of substituted 4-aryloxy- and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of human breast cancer cell proliferationMichael J Gorczynski, Rachel M Leal, Susan L Mooberry, et al.
Plos One|May 12, 2011
YK-4-279 inhibits ERG and ETV1 mediated prostate cancer cell invasionSaid Rahim, Elspeth M Beauchamp, Yali Kong, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 7, 2004
Block of human NaV1.5 sodium channels by novel alpha-hydroxyphenylamide analogues of phenytoinPaul W Lenkowski, Seong-Hoon Ko, James D Anderson, et al.
Tissue Engineering|August 29, 2007
Mechanistic exploration of phthalimide neovascular factor 1 using network analysis toolsKristen A Wieghaus, Erwin P Gianchandani, Milton L Brown, et al.
Pageof 9